Ethosuximide in the treatment of absence (peptit mal) seizures. 1975

T R Browne, and F E Dreifuss, and P R Dyken, and D J Goode, and J K Penry, and R J Porter, and B G White, and P T White

Thirty-seven patients with previously untreated absence seizures were treated with ethosuximide. Seizures were completely controlled in 7 patients (19 percent); 90 to 100 percent control was achieved in 18 patients (49 percent) and 50 to 100 percent control in 35 (95 percent). Plasma ethosuximide concentration increased with dose, but variability in the plasma concentration produced by a given ethosuximide dose made it impossible to predict a patient's plasma concentration from the dose. The therapeutic range of plasma ethosuximide concentration was 40 to 100 mug per milliliter. Patients with evidence of structural central nervous system abnormalities responded as well or better to the drug as patients without such evidence. Ethosuximide did not impair psychometric performance, but rather resulted in improved performance in 17 cases. The side effects of ethosuximide were minor, and rarely required withdrawal of the drug.

UI MeSH Term Description Entries
D008297 Male Males
D011581 Psychological Tests Standardized tests designed to measure abilities (as in intelligence, aptitude, and achievement tests) or to evaluate personality traits. Parenting Stress Index,Trier Social Stress Test,Trier Stress Test,Psychologic Tests,Psychological Test,Test, Psychological,Tests, Psychological,Index, Parenting Stress,Psychologic Test,Stress Index, Parenting,Stress Test, Trier,Test, Psychologic,Test, Trier Stress,Trier Stress Tests
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D004832 Epilepsy, Absence A seizure disorder usually occurring in childhood characterized by rhythmic electrical brain discharges of generalized onset. Clinical features include a sudden cessation of ongoing activity usually without loss of postural tone. Rhythmic blinking of the eyelids or lip smacking frequently accompanies the SEIZURES. The usual duration is 5-10 seconds, and multiple episodes may occur daily. Juvenile absence epilepsy is characterized by the juvenile onset of absence seizures and an increased incidence of myoclonus and tonic-clonic seizures. (Menkes, Textbook of Child Neurology, 5th ed, p736) Akinetic Petit Mal,Epilepsy, Minor,Petit Mal Epilepsy,Pyknolepsy,Absence Seizure Disorder,Childhood Absence Epilepsy,Epilepsy Juvenile Absence,Epilepsy, Absence, Atypical,Epilepsy, Petit Mal,Juvenile Absence Epilepsy,Pykno-Epilepsy,Seizure Disorder, Absence,Absence Epilepsy,Absence Epilepsy, Childhood,Absence Epilepsy, Juvenile,Absence Seizure Disorders,Epilepsy, Childhood Absence,Epilepsy, Juvenile Absence,Minor Epilepsy,Petit Mal, Akinetic,Pykno Epilepsy,Pyknolepsies,Seizure Disorders, Absence
D005013 Ethosuximide An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures. Ethosuccimid,Emeside,Ethylmethylsuccimide,Ethymal,Etosuximida Faes,Petnidan,Pyknolepsinum,Suksilep,Suxilep,Zarontin,Faes, Etosuximida
D005260 Female Females

Related Publications

T R Browne, and F E Dreifuss, and P R Dyken, and D J Goode, and J K Penry, and R J Porter, and B G White, and P T White
December 1982, Developmental medicine and child neurology,
T R Browne, and F E Dreifuss, and P R Dyken, and D J Goode, and J K Penry, and R J Porter, and B G White, and P T White
February 1964, Ugeskrift for laeger,
T R Browne, and F E Dreifuss, and P R Dyken, and D J Goode, and J K Penry, and R J Porter, and B G White, and P T White
February 1982, Neurology,
T R Browne, and F E Dreifuss, and P R Dyken, and D J Goode, and J K Penry, and R J Porter, and B G White, and P T White
January 1983, Acta neurologica Scandinavica. Supplementum,
T R Browne, and F E Dreifuss, and P R Dyken, and D J Goode, and J K Penry, and R J Porter, and B G White, and P T White
January 1966, American journal of diseases of children (1960),
T R Browne, and F E Dreifuss, and P R Dyken, and D J Goode, and J K Penry, and R J Porter, and B G White, and P T White
October 1964, Developmental medicine and child neurology,
T R Browne, and F E Dreifuss, and P R Dyken, and D J Goode, and J K Penry, and R J Porter, and B G White, and P T White
August 1961, British medical journal,
T R Browne, and F E Dreifuss, and P R Dyken, and D J Goode, and J K Penry, and R J Porter, and B G White, and P T White
August 1965, No to shinkei = Brain and nerve,
T R Browne, and F E Dreifuss, and P R Dyken, and D J Goode, and J K Penry, and R J Porter, and B G White, and P T White
March 1963, Nordisk medicin,
T R Browne, and F E Dreifuss, and P R Dyken, and D J Goode, and J K Penry, and R J Porter, and B G White, and P T White
December 1983, Archives of neurology,
Copied contents to your clipboard!